Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis

Mariko Noda1, Akio Suzumura

  • 1Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.

Insights

Microglia, the brain's immune cells, play a crucial role in Alzheimer's disease (AD) by clearing neuronal debris. Impaired microglial phagocytosis and chemotaxis worsen AD pathology and memory deficits.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglia are key immune cells in the central nervous system (CNS).
  • Gliosis, the accumulation of glial cells, is observed in neurodegenerative diseases like Alzheimer's disease (AD).
  • The precise role of microglia in AD pathophysiology remains debated.

Purpose of the Study:

  • To review the implications of microglial chemotaxis and phagocytosis in Alzheimer's disease.
  • To discuss the mechanisms underlying microglial responses to neuronal damage in AD.

Main Methods:

  • Literature review of recent evidence on microglial function in AD.
  • Discussion of microglial chemotaxis towards injured neurons.
  • Analysis of microglial phagocytosis of neuronal debris.

Main Results:

  • Microglial phagocytosis of neuronal debris is essential for maintaining healthy neural networks.
  • Deficiencies in microglial phagocytosis are linked to exacerbated AD pathology.
  • Impaired microglial function can lead to memory impairment in AD.

Conclusions:

  • Microglial chemotaxis and phagocytosis are critical processes in AD.
  • Understanding these microglial functions may offer therapeutic targets for AD.
  • Dysfunctional microglia contribute significantly to AD pathogenesis.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...